A carregar...
Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital
OBJECTIVES: To evaluate the use, effectiveness and safety of tyrosine kinase inhibitors (TKIs) for chronic myelogenous leukaemia (CML) in clinical practice. METHODS: A retrospective longitudinal study of patients with CML who received TKIs for at least 6 months was performed. Endpoints to evaluate e...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7447251/ https://ncbi.nlm.nih.gov/pubmed/32839263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001378 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|